Redefining the role of surgery in early small-cell lung cancer.

Fabian DörrSebastian StangeMaximilian MichelGeorg SchlachtenbergerHruy MengheshaThorsten WahlersKhosro HekmatMatthias B Heldwein

Published in: Langenbeck's archives of surgery (2022)

Based on our data, the role of surgery in stage I and II SCLC is robust, since it improves the long-term survival in both stages significantly. Hence, feasibility of surgery as a priority treatment should always be evaluated not only in stage I SCLC but also in stage II, for which guideline recommendations might have to be reassessed.

Keyphrases

minimally invasive
coronary artery bypass
small cell lung cancer
surgical site infection
electronic health record
percutaneous coronary intervention
machine learning
acute coronary syndrome
clinical practice
atrial fibrillation
combination therapy
data analysis